Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial

Overview of attention for article published in CardioVascular and Interventional Radiology, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 2,732)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 33 news stories from 33 outlets.

Delcath Systems has shared in a press release the publication of updated results from the phase 1b CHOPIN Trial, conducted at…

Updated results in seven patients with advanced uveal melanoma treated with CHEMOSAT and ipilimumab plus nivolumab show a…

Published: Jan. 17, 2023 at 7:00 AM CST|Updated: 25 minutes ago Updated results in seven patients with advanced uveal melanoma…

Updated results in seven patients with advanced uveal melanoma treated with CHEMOSAT and ipilimumab plus nivolumab show a…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 29 additional news stories.